Chemistry Ventures, a venture capital firm founded by former executives from prominent firms like Bessemer and Andreessen Horowitz, is in the process of raising $500 million for its second fund. This announcement came via an SEC filing on July 7, 2026. The firm, which launched two years ago, focuses on early-stage startups that are innovating in the field of artificial intelligence.
Background on Chemistry Ventures
Founded by Mark Goldberg, Ethan Kurzweil, and Kristina Shen, Chemistry Ventures began its journey with a $350 million fund. The founders aimed to leverage their extensive experience from large venture capital firms to support emerging technologies. Their investment strategy primarily targets startups engaged in AI, including those developing infrastructure and applications.
The firm’s portfolio boasts several notable companies, such as Granola, Decagon, Persona, Serval, and Nova Intelligence. This diverse array of investments highlights the firm’s commitment to fostering innovation within the tech sector.
Current Fundraising Status
According to reports from The Wall Street Journal, Chemistry Ventures' second fund is already oversubscribed, indicating strong interest from investors. The fundraising process is expected to close soon, reflecting the growing confidence in AI-driven startups and the firm’s strategic vision.
Goldberg, who previously worked at Index Ventures, alongside Kurzweil from Bessemer and Shen from a16z, has positioned the firm to capitalize on current trends in technology investment. They believe that AI is a critical area for growth, and their second fund will enhance their ability to support promising ventures.
Investment Focus and Future Outlook
Chemistry Ventures aims to continue its focus on early-stage companies in the AI sector. By investing in startups that are pioneering new technologies, the firm seeks to play a pivotal role in shaping the future of artificial intelligence. Their approach combines rigorous analysis with a deep understanding of market trends, ensuring that they are well-positioned to identify and support the next wave of innovation.
As the demand for AI solutions continues to rise, Chemistry Ventures is poised to leverage its expertise and network to drive significant returns for its investors while contributing to the advancement of technology.
- Founded: 2024
- First Fund Size: $350 million
- Current Fundraising: $500 million
- Investment Focus: Early-stage AI startups
- Notable Portfolio Companies: Granola, Decagon, Persona, Serval, Nova Intelligence
🤖 This article was rewritten by Feed and Figures' editorial AI from a report originally published by TechCrunch. Facts and quotes are preserved from the original; the rewrite focuses on clarity and structure. For the unedited original, see the source link below.
